Myopia at Age 9
What to Expect and What to Do
Short answer: A child with myopia at age 9 has approximately 9 years of active eye growth ahead — more than enough time for untreated progression to compound into high myopia. Treatment started now will have a significant cumulative benefit over that period. The IMI 2025 is unambiguous: start at diagnosis.
Clinical picture: what this age means for myopia
The clinical window between age 9 and 12 is where myopia management delivers some of its highest cumulative benefits. Starting at 9 versus 12 gives three additional years of treatment during the fastest growth phase — potentially preventing 0.5–1.0mm of avoidable axial elongation, which could correspond to 1.25–2.50D of final prescription difference.
What parents should do now
- Confirm your optometrist is measuring axial length — not just refraction
- If not already started, begin myopia management at this appointment
- 6-month review cycles standard at this age
- Track progression with two consecutive AL measurements
Treatment options at age 9
All options available: MiSight®, Stellest®, orthokeratology, atropine. Choice depends on contact lens readiness, compliance profile, and progression rate.
See your child's projected prescription at age 18
Enter current age, axial length, and a prior measurement. Get projected adult prescription with and without treatment — in under 60 seconds.
Project myopia progression →How age at onset predicts lifetime risk
| Age myopia starts | Years of fast growth remaining | High myopia risk (without treatment) |
|---|---|---|
| Age 6 | ~12 years | Very high (est. 60–80%) |
| Age 7 | ~11 years | Very high (est. 55–75%) |
| Age 8 | ~10 years | High (est. 45–65%) |
| Age 9 | ~9 years | High (est. 35–55%) |
| Age 10 | ~8 years | Moderate–High (est. 25–45%) |
| Age 12 | ~6 years | Moderate (est. 15–30%) |
| Age 14 | ~4 years | Lower (est. 10–20%) |
| Age 16 | ~2 years | Low (est. 5–12%) |
High myopia defined as ≥−6.00D. Risk estimates based on Tideman 2018 longitudinal data; individual outcomes vary substantially. Your row is highlighted.
This page is for educational purposes and does not constitute medical advice. Diopter-to-axial-length conversions are approximations (±2–3D individual variation). MyopiaTracker is a decision-support tool — not a diagnostic device. Consult a qualified optometrist or ophthalmologist for personalised advice.